Publication|Articles|September 13, 2024
- Applied Clinical Trials-09-01-2024
- Volume 33
- Issue 9
Applied Clinical Trials September 2024 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials September 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Aligning Technology and Oversightalmost 2 years ago
A New Regulatory Road in Clinical Trials: Digital Twinsalmost 2 years ago
Bridging Patient Support Gaps While Navigating Global Regulationsalmost 2 years ago
Regulatory CMC: Enhancing Biologics Developmentalmost 2 years ago
In Focus: Top Takeaways from FDA Final Guidance on Real-World Evidencealmost 2 years ago
Driving Inclusion in Clinical Trials: Less Talk, More Trustalmost 2 years ago
Risk Planning: A Review of Industry Trendsabout 2 years ago
An Overview of FDA Diversity-Related Documents for Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The AI Churn Trap in Life Sciences and How to Break It
2
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
3
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
4
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
5